AI-derived predictive biomarker identifies two thirds of patients with high-risk prostate cancer who may benefit from ...

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

Discover the role of commensal bacteria in the progression of prostate cancer and the potential treatment impacts.

Medically reviewed by Matthew Wosnitzer, MD Most prostate cancers eventually stop responding to androgen deprivation therapy ...

It used to be that radiation therapy for prostate cancer involved weeks or months of repeat visits to a clinic for treatment.

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...

Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...

Using advanced imaging technologies as a means to enhance diagnostic accuracy was also of interest. Many HCPs pointed to the ...

Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.

Sophia Kamran, MD, discusses how salvage therapy after biochemical recurrence may improve outcomes for patients with prostate ...

Women who incorporated testosterone into their hormone replacement therapy regimen through bioidentical ... Alzheimer's disease, prostate cancer, and more. Experience the power of hormone ...